Yayın:
Evaluation and follow-up of antibody formation after CoronaVac vaccine

dc.contributor.authorÇalişir, Büşra
dc.contributor.authorÇöplü, Nilay
dc.contributor.authorYasar-Duman, Melike
dc.contributor.authorKilinc, Cetin
dc.contributor.authorOzbek, Ridvan
dc.contributor.authorDemir, Celal
dc.contributor.authorErgül, Zafer
dc.date.accessioned2026-01-04T16:23:24Z
dc.date.issued2022-01-01
dc.description.abstractThe aim of this study was to monitor the time-dependent change by evaluating the antibody levels at the 4th, 7th, 10th, 13th, and 16th weeks after the second dose of the CoronaVac vaccine.The study group (n=65) were between 21 and 60 years old and received two doses of the CoronaVac vaccine. Blood samples were collected after 4th, 7th, 10th, 13th, and 16th weeks of the second dose of the vaccine administration. There was a coronavirus disease 2019 recovered group (n=29) who were SARS-CoV-2 real-time PCR test result positive before the vaccination period, and no coronavirus disease 2019 history group (n=36). Age, BMI, gender, smoking, comorbidity, coronavirus disease 2019 contact history, and working in the coronavirus disease 2019 service history of the individuals were recorded.No statistically significant difference was found in the descriptive findings of the individuals according to coronavirus disease 2019 recovered group and no coronavirus disease 2019 history group. It was observed that antibody levels in the coronavirus disease 2019 recovered group were found to be higher for each period of serum collection compared to the no coronavirus disease 2019 history group, which were statistically significant. The distribution curves of the antibody levels according to the timing of blood collection in coronavirus disease 2019 recovered group, no coronavirus disease 2019 history group, and total subjects were extrapolated, and it was observed that the estimated time for the antibodies to reach the threshold value of the test was 214, 145, and 166 days after vaccination.It is important to make booster doses, as the CoronaVac vaccine will lose its effect after the fifth month due to the decrease in Ab levels. In addition, since the antibody levels decrease later in those who have a history of coronavirus disease 2019 infection and are vaccinated, individuals who have no previous history of coronavirus disease 2019 should be given priority for vaccination.
dc.description.urihttps://doi.org/10.1590/1806-9282.20221074
dc.description.urihttps://pubmed.ncbi.nlm.nih.gov/36477105
dc.description.urihttp://dx.doi.org/10.1590/1806-9282.20221074
dc.description.urihttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302022001201769
dc.description.urihttps://avesis.uludag.edu.tr/publication/details/96565b53-b320-4efd-9d80-306e2658154c/oai
dc.description.urihttp://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302022005015205&lng=en&tlng=en
dc.description.urihttp://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302022001201769&lng=en&tlng=en
dc.identifier.doi10.1590/1806-9282.20221074
dc.identifier.eissn1806-9282
dc.identifier.endpage1773
dc.identifier.issn0104-4230
dc.identifier.openairedoi_dedup___::824adba67fdea80a3cff00f231925f42
dc.identifier.orcid0000-0001-6257-5422
dc.identifier.orcid0000-0003-1956-1417
dc.identifier.orcid0000-0001-8913-2314
dc.identifier.orcid0000-0003-4958-2622
dc.identifier.orcid0000-0002-9552-5429
dc.identifier.orcid0000-0002-4092-000x
dc.identifier.orcid0000-0002-0310-9218
dc.identifier.pubmed36477105
dc.identifier.scopus2-s2.0-85144590515
dc.identifier.startpage1769
dc.identifier.urihttps://hdl.handle.net/20.500.12597/39419
dc.identifier.volume68
dc.identifier.wos000904384200033
dc.publisherFapUNIFESP (SciELO)
dc.relation.ispartofRevista da Associação Médica Brasileira
dc.rightsOPEN
dc.subjectAdult
dc.subjectVaccines
dc.subjectSARS-CoV-2
dc.subjectınactivated
dc.subjectImmunity
dc.subjectCOVID-19
dc.subjectMiddle Aged
dc.subjectAntibodies, Viral
dc.subjecthumoral
dc.subjectYoung Adult
dc.subjectAntibody Formation
dc.subjectHumans
dc.subjectOriginal Article
dc.subjectFollow-Up Studies
dc.subject.sdg3. Good health
dc.titleEvaluation and follow-up of antibody formation after CoronaVac vaccine
dc.typeArticle
dspace.entity.typePublication
local.api.response{"authors":[{"fullName":"Büşra Çalişir","name":"Büşra","surname":"Çalişir","rank":1,"pid":{"id":{"scheme":"orcid","value":"0000-0001-6257-5422"},"provenance":null}},{"fullName":"Nilay Çöplü","name":"Nilay","surname":"Çöplü","rank":2,"pid":{"id":{"scheme":"orcid","value":"0000-0003-1956-1417"},"provenance":null}},{"fullName":"Melike Yasar-Duman","name":"Melike","surname":"Yasar-Duman","rank":3,"pid":{"id":{"scheme":"orcid","value":"0000-0001-8913-2314"},"provenance":null}},{"fullName":"Cetin Kilinc","name":"Cetin","surname":"Kilinc","rank":4,"pid":{"id":{"scheme":"orcid","value":"0000-0003-4958-2622"},"provenance":null}},{"fullName":"Ridvan Ozbek","name":"Ridvan","surname":"Ozbek","rank":5,"pid":{"id":{"scheme":"orcid","value":"0000-0002-9552-5429"},"provenance":null}},{"fullName":"Celal Demir","name":"Celal","surname":"Demir","rank":6,"pid":{"id":{"scheme":"orcid_pending","value":"0000-0002-4092-000x"},"provenance":null}},{"fullName":"Zafer Ergül","name":"Zafer","surname":"Ergül","rank":7,"pid":{"id":{"scheme":"orcid_pending","value":"0000-0002-0310-9218"},"provenance":null}}],"openAccessColor":"gold","publiclyFunded":false,"type":"publication","language":{"code":"und","label":"Undetermined"},"countries":null,"subjects":[{"subject":{"scheme":"keyword","value":"Adult"},"provenance":null},{"subject":{"scheme":"FOS","value":"0301 basic medicine"},"provenance":null},{"subject":{"scheme":"keyword","value":"Vaccines"},"provenance":null},{"subject":{"scheme":"FOS","value":"0303 health sciences"},"provenance":null},{"subject":{"scheme":"keyword","value":"SARS-CoV-2"},"provenance":null},{"subject":{"scheme":"keyword","value":"ınactivated"},"provenance":null},{"subject":{"scheme":"keyword","value":"Immunity"},"provenance":null},{"subject":{"scheme":"keyword","value":"COVID-19"},"provenance":null},{"subject":{"scheme":"keyword","value":"Middle Aged"},"provenance":null},{"subject":{"scheme":"keyword","value":"Antibodies, Viral"},"provenance":null},{"subject":{"scheme":"SDG","value":"3. Good health"},"provenance":null},{"subject":{"scheme":"keyword","value":"humoral"},"provenance":null},{"subject":{"scheme":"keyword","value":"Young Adult"},"provenance":null},{"subject":{"scheme":"FOS","value":"03 medical and health sciences"},"provenance":null},{"subject":{"scheme":"keyword","value":"Antibody Formation"},"provenance":null},{"subject":{"scheme":"keyword","value":"Humans"},"provenance":null},{"subject":{"scheme":"keyword","value":"Original Article"},"provenance":null},{"subject":{"scheme":"keyword","value":"Follow-Up Studies"},"provenance":null}],"mainTitle":"Evaluation and follow-up of antibody formation after CoronaVac vaccine","subTitle":null,"descriptions":["The aim of this study was to monitor the time-dependent change by evaluating the antibody levels at the 4th, 7th, 10th, 13th, and 16th weeks after the second dose of the CoronaVac vaccine.The study group (n=65) were between 21 and 60 years old and received two doses of the CoronaVac vaccine. Blood samples were collected after 4th, 7th, 10th, 13th, and 16th weeks of the second dose of the vaccine administration. There was a coronavirus disease 2019 recovered group (n=29) who were SARS-CoV-2 real-time PCR test result positive before the vaccination period, and no coronavirus disease 2019 history group (n=36). Age, BMI, gender, smoking, comorbidity, coronavirus disease 2019 contact history, and working in the coronavirus disease 2019 service history of the individuals were recorded.No statistically significant difference was found in the descriptive findings of the individuals according to coronavirus disease 2019 recovered group and no coronavirus disease 2019 history group. It was observed that antibody levels in the coronavirus disease 2019 recovered group were found to be higher for each period of serum collection compared to the no coronavirus disease 2019 history group, which were statistically significant. The distribution curves of the antibody levels according to the timing of blood collection in coronavirus disease 2019 recovered group, no coronavirus disease 2019 history group, and total subjects were extrapolated, and it was observed that the estimated time for the antibodies to reach the threshold value of the test was 214, 145, and 166 days after vaccination.It is important to make booster doses, as the CoronaVac vaccine will lose its effect after the fifth month due to the decrease in Ab levels. In addition, since the antibody levels decrease later in those who have a history of coronavirus disease 2019 infection and are vaccinated, individuals who have no previous history of coronavirus disease 2019 should be given priority for vaccination."],"publicationDate":"2022-01-01","publisher":"FapUNIFESP (SciELO)","embargoEndDate":null,"sources":["Crossref","Rev Assoc Med Bras (1992)","Revista da Associação Médica Brasileira v.68 n.12 2022","reponame:Revista da Associação Médica Brasileira (Online)","instname:Associação Médica Brasileira (AMB)","instacron:AMB","Revista da Associação Médica Brasileira, Issue: ahead, Published: 05 DEC 2022","Revista da Associação Médica Brasileira, Volume: 68, Issue: 12, Pages: 1769-1773, Published: 05 DEC 2022"],"formats":["text/html"],"contributors":null,"coverages":null,"bestAccessRight":{"code":"c_abf2","label":"OPEN","scheme":"http://vocabularies.coar-repositories.org/documentation/access_rights/"},"container":{"name":"Revista da Associação Médica Brasileira","issnPrinted":"0104-4230","issnOnline":"1806-9282","issnLinking":null,"ep":"1773","iss":null,"sp":"1769","vol":"68","edition":null,"conferencePlace":null,"conferenceDate":null},"documentationUrls":null,"codeRepositoryUrl":null,"programmingLanguage":null,"contactPeople":null,"contactGroups":null,"tools":null,"size":null,"version":null,"geoLocations":null,"id":"doi_dedup___::824adba67fdea80a3cff00f231925f42","originalIds":["S0104-42302022001201769","10.1590/1806-9282.20221074","50|doiboost____|824adba67fdea80a3cff00f231925f42","od_______267::434f013c3fc1774f322174f5d71c9736","36477105","PMC9779953","oai:pubmedcentral.nih.gov:9779953","50|od_______267::434f013c3fc1774f322174f5d71c9736","50|od______3056::e44768a9f84f9b4ec91b6d6dc0db9289","oai:scielo:S0104-42302022001201769","50|od______9458::b5540d4ae5c47242fb3614980de20c71","96565b53-b320-4efd-9d80-306e2658154c","50|od_______608::c37eb67480c2df233421220b26a557e3","oai:scielo:S0104-42302022005015205","50|od_______608::e44768a9f84f9b4ec91b6d6dc0db9289"],"pids":[{"scheme":"doi","value":"10.1590/1806-9282.20221074"},{"scheme":"pmid","value":"36477105"},{"scheme":"pmc","value":"PMC9779953"}],"dateOfCollection":null,"lastUpdateTimeStamp":null,"indicators":{"citationImpact":{"citationCount":2,"influence":2.65301e-9,"popularity":3.4111054e-9,"impulse":2,"citationClass":"C5","influenceClass":"C5","impulseClass":"C5","popularityClass":"C5"}},"instances":[{"pids":[{"scheme":"doi","value":"10.1590/1806-9282.20221074"}],"license":"CC BY NC","type":"Article","urls":["https://doi.org/10.1590/1806-9282.20221074"],"publicationDate":"2022-01-01","refereed":"peerReviewed"},{"pids":[{"scheme":"pmid","value":"36477105"},{"scheme":"pmc","value":"PMC9779953"}],"alternateIdentifiers":[{"scheme":"doi","value":"10.1590/1806-9282.20221074"}],"type":"Article","urls":["https://pubmed.ncbi.nlm.nih.gov/36477105"],"publicationDate":"2022-12-23","refereed":"nonPeerReviewed"},{"alternateIdentifiers":[{"scheme":"doi","value":"10.1590/1806-9282.20221074"}],"license":"http://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","type":"Other literature type","urls":["http://dx.doi.org/10.1590/1806-9282.20221074"],"publicationDate":"2022-12-05","refereed":"nonPeerReviewed"},{"type":"Article","urls":["http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302022001201769"],"publicationDate":"2022-01-01","refereed":"nonPeerReviewed"},{"alternateIdentifiers":[{"scheme":"doi","value":"10.1590/1806-9282.20221074"}],"type":"Article","urls":["https://avesis.uludag.edu.tr/publication/details/96565b53-b320-4efd-9d80-306e2658154c/oai"],"publicationDate":"2022-01-01","refereed":"nonPeerReviewed"},{"license":"CC BY NC","type":"Article","urls":["http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302022005015205&lng=en&tlng=en"],"publicationDate":"2022-12-05","refereed":"nonPeerReviewed"},{"license":"CC BY NC","type":"Article","urls":["http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302022001201769&lng=en&tlng=en"],"publicationDate":"2022-12-05","refereed":"nonPeerReviewed"}],"isGreen":true,"isInDiamondJournal":false}
local.import.sourceOpenAire
local.indexed.atWOS
local.indexed.atScopus
local.indexed.atPubMed

Dosyalar

Koleksiyonlar